JP2019201661A5 - - Google Patents

Download PDF

Info

Publication number
JP2019201661A5
JP2019201661A5 JP2019141485A JP2019141485A JP2019201661A5 JP 2019201661 A5 JP2019201661 A5 JP 2019201661A5 JP 2019141485 A JP2019141485 A JP 2019141485A JP 2019141485 A JP2019141485 A JP 2019141485A JP 2019201661 A5 JP2019201661 A5 JP 2019201661A5
Authority
JP
Japan
Prior art keywords
composition according
composition
culture medium
cells
adamts13
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019141485A
Other languages
English (en)
Japanese (ja)
Other versions
JP6883071B2 (ja
JP2019201661A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019201661A publication Critical patent/JP2019201661A/ja
Publication of JP2019201661A5 publication Critical patent/JP2019201661A5/ja
Priority to JP2021079239A priority Critical patent/JP7083059B2/ja
Application granted granted Critical
Publication of JP6883071B2 publication Critical patent/JP6883071B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019141485A 2009-07-31 2019-07-31 Adamtsタンパク質発現のための細胞培養培地 Active JP6883071B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021079239A JP7083059B2 (ja) 2009-07-31 2021-05-07 Adamtsタンパク質発現のための細胞培養培地

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23047709P 2009-07-31 2009-07-31
US61/230,477 2009-07-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018011373A Division JP6567707B2 (ja) 2009-07-31 2018-01-26 Adamtsタンパク質発現のための細胞培養培地

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021079239A Division JP7083059B2 (ja) 2009-07-31 2021-05-07 Adamtsタンパク質発現のための細胞培養培地

Publications (3)

Publication Number Publication Date
JP2019201661A JP2019201661A (ja) 2019-11-28
JP2019201661A5 true JP2019201661A5 (enExample) 2020-01-23
JP6883071B2 JP6883071B2 (ja) 2021-06-09

Family

ID=42668009

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2012523110A Active JP5451884B2 (ja) 2009-07-31 2010-07-30 Adamtsタンパク質発現のための細胞培養培地
JP2016093240A Active JP6511007B2 (ja) 2009-07-31 2016-05-06 Adamtsタンパク質発現のための細胞培養培地
JP2018011373A Active JP6567707B2 (ja) 2009-07-31 2018-01-26 Adamtsタンパク質発現のための細胞培養培地
JP2019141485A Active JP6883071B2 (ja) 2009-07-31 2019-07-31 Adamtsタンパク質発現のための細胞培養培地
JP2021079239A Active JP7083059B2 (ja) 2009-07-31 2021-05-07 Adamtsタンパク質発現のための細胞培養培地

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2012523110A Active JP5451884B2 (ja) 2009-07-31 2010-07-30 Adamtsタンパク質発現のための細胞培養培地
JP2016093240A Active JP6511007B2 (ja) 2009-07-31 2016-05-06 Adamtsタンパク質発現のための細胞培養培地
JP2018011373A Active JP6567707B2 (ja) 2009-07-31 2018-01-26 Adamtsタンパク質発現のための細胞培養培地

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021079239A Active JP7083059B2 (ja) 2009-07-31 2021-05-07 Adamtsタンパク質発現のための細胞培養培地

Country Status (21)

Country Link
US (7) US8313926B2 (enExample)
EP (1) EP2459702B1 (enExample)
JP (5) JP5451884B2 (enExample)
KR (5) KR101912552B1 (enExample)
CN (2) CN104962539B (enExample)
AU (1) AU2010278751B2 (enExample)
BR (2) BR112012002151B1 (enExample)
CA (1) CA2769361A1 (enExample)
CO (1) CO6501191A2 (enExample)
EA (1) EA023193B1 (enExample)
ES (1) ES2583258T3 (enExample)
HR (1) HRP20160783T1 (enExample)
HU (1) HUE029110T2 (enExample)
IN (1) IN2012DN00801A (enExample)
MX (2) MX2012001261A (enExample)
NZ (1) NZ597727A (enExample)
PL (1) PL2459702T3 (enExample)
PT (1) PT2459702T (enExample)
SG (1) SG178194A1 (enExample)
SI (1) SI2459702T1 (enExample)
WO (1) WO2011014838A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012002151B1 (pt) * 2009-07-31 2021-07-06 Baxalta GmbH método para expressar uma desintegrina e metaloproteinase com proteína de motivo trombospondina (adamts)
ES3037386T3 (en) 2010-07-08 2025-10-01 Takeda Pharmaceuticals Co Method of producing recombinant high molecular weight vwf in cell culture
HUE033279T2 (en) 2011-07-01 2017-11-28 Amgen Inc Mammalian cell culture
CN104822826B (zh) 2012-10-15 2019-04-30 百时美施贵宝公司 用于蛋白产生的哺乳动物细胞培养过程
US9611455B2 (en) 2013-03-13 2017-04-04 Merck Sharp & Dohme Corp. Adapted lepidopteran insect cells for the production of recombinant proteins
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
KR102418824B1 (ko) * 2013-10-14 2022-07-11 아레스 트레이딩 에스.아. 포유동물의 고성능 유가식 배양을 위한 신규 배지
ES2909630T3 (es) 2014-06-04 2022-05-09 Amgen Inc Métodos de recolección en cultivos de células de mamífero
KR101867134B1 (ko) * 2015-03-23 2018-06-12 한양대학교 산학협력단 포유류 세포를 이용하여 목적 물질을 고효율로 생산하기 위한 세포 배양 배지, 이를 이용한 세포 배양 방법 및 목적 물질의 생산 방법
CN107636151B (zh) * 2015-05-22 2023-04-04 杜邦营养生物科学有限公司 乙酰乳酸脱羧酶
TW202440903A (zh) 2015-08-04 2024-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法(一)
NZ750146A (en) 2016-08-04 2025-10-31 Takeda Pharmaceuticals Co Use of adamts13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
MX2019004784A (es) * 2016-11-04 2019-08-12 Baxalta Inc Metodos de purificacion del virus adeno-asociado.
MX2020000228A (es) * 2017-07-06 2020-08-10 Regeneron Pharma Proceso de cultivo celular para producir una glicoproteina.
BR112020018823A2 (pt) * 2018-03-16 2021-02-09 Genzyme Corporation métodos para aperfeiçoar viabilidade de célula em um biorreator de produção
WO2019245938A1 (en) * 2018-06-18 2019-12-26 Synthetic Biologics, Inc. Methods of making alkaline phosphatase agents
WO2021067668A1 (en) 2019-10-04 2021-04-08 The Children's Medical Center Corporation Adamts13 treatment to enhance graft survival
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
JP2022548197A (ja) 2019-12-06 2022-11-17 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 抗vegfタンパク質組成物及びその製造方法
AU2021248679A1 (en) 2020-04-02 2022-10-27 Takeda Pharmaceutical Company Limited ADAMTS13 variant, compositions, and uses thereof
CN115803009A (zh) 2020-05-08 2023-03-14 瑞泽恩制药公司 用于治疗眼病和癌症的vegf阱和微阱及方法
WO2021234458A1 (en) 2020-05-22 2021-11-25 Takeda Pharmaceutical Company Limited Adamts13 compositions and methods for treating and diagnosing complications of coronavirus disease
WO2021246557A1 (ko) * 2020-06-05 2021-12-09 주식회사 프로앱텍 특정한 갯수의 알부민이 연결된 요산산화효소-알부민 복합체 및 이의 제조 방법
CN111808822B (zh) * 2020-07-02 2024-01-12 北京百普赛斯生物科技股份有限公司 细胞培养用补料液及提高重组hek293细胞蛋白表达量的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5250421A (en) 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
JPH0753104B2 (ja) * 1989-02-28 1995-06-07 秀明 山田 細菌の培養法
CZ280901B6 (cs) 1988-10-06 1996-05-15 Hideaki Yamada Způsob kultivace bakterií
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
ES2323490T3 (es) 1994-11-10 2009-07-17 Baxter Healthcare Sa Procedimiento de produccion de agentes biologicos en un medio de cultivo sin proteinas.
EP0811056B1 (en) 1995-02-23 2000-05-31 Quest International B.V. Peptides for tissue and cell culture media
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
IT1285158B1 (it) 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il
WO1998015514A1 (en) 1996-10-07 1998-04-16 Solutia Inc. Process for the hydroxylation of benzene
AU4751697A (en) 1996-10-10 1998-05-05 Douglas Danner Animal cell culture media comprising plant-derived nutrients
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6406909B1 (en) 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6926894B2 (en) 2000-11-22 2005-08-09 Baxter Aktiengesellschaft Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
EP1576148B1 (en) 2002-12-23 2012-10-03 FUJIFILM Manufacturing Europe B.V. Process for coating cell-culture support
EP1737953A2 (en) * 2004-04-16 2007-01-03 Wyeth a Corporation of the State of Delaware Adamts-8 proteins and uses thereof
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
JP2007174948A (ja) * 2005-12-27 2007-07-12 Noritsu Koki Co Ltd 酵素水製造装置
JP4880997B2 (ja) * 2005-12-28 2012-02-22 アルフレッサファーマ株式会社 Adamts13の安定化方法
ES2474573T3 (es) * 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
WO2008077217A2 (en) * 2006-12-22 2008-07-03 Springer Carrier Ltda. Fresh air command lever for an air conditioning unit
US20090067805A1 (en) 2007-09-10 2009-03-12 Victor Company Of Japan, Limited Recording and reproducing device
PL2235197T3 (pl) * 2007-12-27 2018-01-31 Baxalta GmbH Sposoby hodowli komórek
BR112012002151B1 (pt) * 2009-07-31 2021-07-06 Baxalta GmbH método para expressar uma desintegrina e metaloproteinase com proteína de motivo trombospondina (adamts)

Similar Documents

Publication Publication Date Title
JP2019201661A5 (enExample)
JP2013500724A5 (enExample)
HRP20160783T1 (hr) Medij za kultiviranje stanica za ekspresiju adamts proteina
US11136373B2 (en) Fermentation process for increasing production level of recombinant human collagen
Parks et al. Enhanced measles virus cDNA rescue and gene expression after heat shock
DE69720026D1 (de) Verfahren zur herstellung von d-aminosäuren durch direkte gärung
DE60315925D1 (de) Verfahren zur Herstellung einer Zielsubstanz durch Fermentation mittels eines bakteriellen Stamms, dem das ArcA-Gen fehlt
IE68408B1 (en) Purification of hepatitis proteins
JP2017531425A5 (enExample)
JP7459362B1 (ja) 組換えヒト型化コラーゲンおよびその応用
BR0012712B1 (pt) métodos de produção de l-aminoácidos aumentando-se o nadph celular.
DE60120619D1 (de) Verfahren zur Herstellung einer Zielsubstanz durch Fermentation
DE69931394D1 (de) Verfahren zur herstellung von ascorbinsäure-zwischenprodukten
CN102876630A (zh) 一种高效分离和扩增人脐带血间充质干细胞的方法
JP2010531148A5 (enExample)
JPWO2020179380A5 (enExample)
CN111218477A (zh) 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用
JP2014518508A5 (enExample)
CN106916775A (zh) 高产纳米多聚磷酸体的转基因藻株及其制备方法
JP2005511087A5 (enExample)
US20220010286A1 (en) Process for producing a purified rhabdovirus from cell culture
CN115651078A (zh) 重组纤连-胶原蛋白高纯度高效率制备方法
US20230414665A1 (en) Method for producing modified mesenchymal stromal stem cells with improved properties, modified cells obtained by this method, composition including such cells
CN105601726B (zh) Oct4在调控IL-31基因表达中的应用
CN110694059A (zh) 一种大规模培养cho细胞以制备乙型肝炎疫苗的方法